Mayne Pharma Inc has recalled 8,274 bottles of Carbidopa and Levodopa tablets (25 mg/250 mg) because a foreign tablet was discovered inside a bottle. This product mix-up means a patient could accidentally ingest the wrong medication, which may not provide the intended treatment for Parkinson's disease or could cause an adverse reaction. These prescription tablets were distributed nationwide in 100-count bottles. Consumers who have this medication should check their bottle's lot number and expiration date immediately and consult their pharmacist if they find a mismatch.
The presence of a foreign tablet in the bottle poses a risk of a patient taking an incorrect medication instead of their prescribed Carbidopa and Levodopa. This can lead to ineffective treatment of their condition or unexpected side effects from the unintended drug.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.